Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies.
Cancer
; 125(3): 463-472, 2019 02 01.
Article
in En
| MEDLINE
| ID: mdl-30383888
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Skin Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Carboplatin
/
Paclitaxel
/
Vemurafenib
/
Melanoma
/
Neoplasms
Type of study:
Prognostic_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Cancer
Year:
2019
Type:
Article